{"entity":{"type":"insider","cik":"0001977970","url":"/insider/0001977970","json_url":"/insider/0001977970.json","name":"Nguyen AnhCo","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":13,"first":"2023-08-18","last":"2026-08-26","span_basis":"filed_date"},"name_variants":[{"name":"Nguyen AnhCo","source":"filing","n_filings":13,"first_seen":"2023-08-18","last_seen":"2026-08-26"}],"transactions":[{"id":9302140,"accession":"0000905148-26-003960","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-26-003960","line_url":"/filing/0000905148-26-003960#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5062.0,"shares_display":"5,062","price_per_share":8.0764,"price_display":"8.08","price_state":"stated","total_value":40882.7368,"total_display":"40,882.74","total_whole":"40,883","shares_owned_after":132775.0,"shares_owned_after_display":"132,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-26","scope":"insider"},{"id":6145928,"accession":"0000905148-26-002571","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-26-002571","line_url":"/filing/0000905148-26-002571#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5241.0,"shares_display":"5,241","price_per_share":9.1289,"price_display":"9.13","price_state":"stated","total_value":47844.5649,"total_display":"47,844.56","total_whole":"47,845","shares_owned_after":137837.0,"shares_owned_after_display":"137,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider"},{"id":5761091,"accession":"0000905148-26-001143","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000905148-26-001143","line_url":"/filing/0000905148-26-001143","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2996.0,"shares_display":"2,996","price_per_share":5.085902536715621,"price_display":"5.09","price_state":"stated","total_value":15237.364,"total_display":"15,237.36","total_whole":"15,237","shares_owned_after":61978.0,"shares_owned_after_display":"61,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider","n_lines":4},{"id":4573837,"accession":"0000905148-25-004141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-25-004141","line_url":"/filing/0000905148-25-004141","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2915.0,"shares_display":"2,915","price_per_share":13.186038421955404,"price_display":"13.19","price_state":"stated","total_value":38437.302,"total_display":"38,437.30","total_whole":"38,437","shares_owned_after":65030.0,"shares_owned_after_display":"65,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider","n_lines":2},{"id":4058372,"accession":"0000905148-25-003070","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-25-003070","line_url":"/filing/0000905148-25-003070","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2958.0,"shares_display":"2,958","price_per_share":11.616056795131845,"price_display":"11.62","price_state":"stated","total_value":34360.296,"total_display":"34,360.30","total_whole":"34,360","shares_owned_after":67889.0,"shares_owned_after_display":"67,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider","n_lines":3},{"id":4939284,"accession":"0000905148-25-001865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-25-001865","line_url":"/filing/0000905148-25-001865#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3276.0,"shares_display":"3,276","price_per_share":6.763,"price_display":"6.76","price_state":"stated","total_value":22155.588,"total_display":"22,155.59","total_whole":"22,156","shares_owned_after":70847.0,"shares_owned_after_display":"70,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"},{"id":5021768,"accession":"0000905148-25-000865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-25-000865","line_url":"/filing/0000905148-25-000865#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3331.0,"shares_display":"3,331","price_per_share":6.997,"price_display":"7.00","price_state":"stated","total_value":23307.007,"total_display":"23,307.01","total_whole":"23,307","shares_owned_after":74123.0,"shares_owned_after_display":"74,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":2170651,"accession":"0000905148-24-003241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-003241","line_url":"/filing/0000905148-24-003241#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1664.0,"shares_display":"1,664","price_per_share":11.198,"price_display":"11.20","price_state":"stated","total_value":18633.472,"total_display":"18,633.47","total_whole":"18,633","shares_owned_after":77454.0,"shares_owned_after_display":"77,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-20","scope":"insider"},{"id":3067195,"accession":"0000905148-24-002305","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-24-002305","line_url":"/filing/0000905148-24-002305","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Officer (EVP, Chief Sci. & Tech Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Sci. & Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Sci. & Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1821.0,"shares_display":"1,821","price_per_share":6.629224601867106,"price_display":"6.63","price_state":"stated","total_value":12071.818,"total_display":"12,071.82","total_whole":"12,072","shares_owned_after":34471.0,"shares_owned_after_display":"34,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-20","scope":"insider","n_lines":3},{"id":3106616,"accession":"0000905148-24-001560","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-001560","line_url":"/filing/0000905148-24-001560#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Officer (EVP, Chief Sci. & Tech Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Sci. & Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Sci. & Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42899.0,"shares_display":"42,899","price_per_share":0.617,"price_display":"0.62","price_state":"stated","total_value":26468.683,"total_display":"26,468.68","total_whole":"26,469","shares_owned_after":898498.0,"shares_owned_after_display":"898,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":2035188,"accession":"0000905148-24-000910","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-000910","line_url":"/filing/0000905148-24-000910#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Officer (EVP, Chief Sci. & Tech Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Sci. & Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Sci. & Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10746.0,"shares_display":"10,746","price_per_share":0.72,"price_display":"0.72","price_state":"stated","total_value":7737.12,"total_display":"7,737.12","total_whole":"7,737","shares_owned_after":941397.0,"shares_owned_after_display":"941,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8280704,"accession":"0000905148-23-001512","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-23-001512","line_url":"/filing/0000905148-23-001512#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Officer (EVP, Chief Sci. & Tech Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Sci. & Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Sci. & Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8856.0,"shares_display":"8,856","price_per_share":0.389,"price_display":"0.39","price_state":"stated","total_value":3444.984,"total_display":"3,444.98","total_whole":"3,445","shares_owned_after":277143.0,"shares_owned_after_display":"277,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"},{"id":8604601,"accession":"0001140361-23-040561","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-040561","line_url":"/filing/0001140361-23-040561","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001977970","owner_name":"Nguyen AnhCo","owner_display_name":"Nguyen AnhCo","owner_url":"/insider/0001977970","role":"Officer (EVP, Chief Sci. & Tech Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Sci. & Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Sci. & Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15126.0,"shares_display":"15,126","price_per_share":1.6526133148221605,"price_display":"1.65","price_state":"stated","total_value":24997.429,"total_display":"24,997.43","total_whole":"24,997","shares_owned_after":285999.0,"shares_owned_after_display":"285,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-18","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Director, Officer (President and CEO)","n_filings":13,"first_seen":"2023-08-18","last_seen":"2026-08-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001977970","retrieved_at":"2026-08-27T12:36:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}